The global response to the COVID-19 pandemic, characterized by mass vaccination campaigns and widespread viral exposure, has inadvertently created a…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is undergoing a seismic shift as pharmaceutical giants Merck & Co. and Moderna reach a pivotal…
Read More
Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has shifted significantly in the wake of the COVID-19 pandemic, leaving the vast majority of…
Read MoreMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna advance their…
Read MoreCancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a massive, highly specific reservoir…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna move toward…
Read More
Cancer vaccine borrows COVID immune memory to activate T cells against tumors in mice
The global landscape of immunology has been irrevocably altered by the COVID-19 pandemic, leaving behind a massive, worldwide cohort of…
Read More
US FDA Commissioner Nominee Dr Heidi Overton Defends MMR Vaccine Safety During Contentious Senate Confirmation Hearing
During a high-stakes and politically charged Senate confirmation hearing, Dr Heidi Overton, President Donald Trump’s nominee to lead the US…
Read More
HHS seeks nominees for vaccine advisory panel with $757K estimated annual cost after almost two years without a meeting
The United States Department of Health and Human Services (HHS) has officially issued a formal solicitation for nominations to the…
Read More
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
The landscape of oncology is currently undergoing a paradigm shift as pharmaceutical giants Merck & Co. and Moderna transition from…
Read More
